These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38256902)

  • 1. Use of Exposure Data to Establish Causality in Drug-Adverse Event Relationships: An Example with Desvenlafaxine.
    Rodríguez-Lopez A; Mejía-Abril G; Zubiaur P; Calleja S; Román M; Abad-Santos F; Ochoa D
    Pharmaceuticals (Basel); 2024 Jan; 17(1):. PubMed ID: 38256902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
    Foster RH; Goa KL
    CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring drug safety in Astrakhan, Russia.
    Kirilochev OO; Dorfman IP; Umerova AR
    Int J Risk Saf Med; 2015; 27 Suppl 1():S33-4. PubMed ID: 26639700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A quantitative approach of using genetic algorithm in designing a probability scoring system of an adverse drug reaction assessment system.
    Koh Y; Yap CW; Li SC
    Int J Med Inform; 2008 Jun; 77(6):421-30. PubMed ID: 17921048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of polymorphisms in
    Calleja S; Zubiaur P; Ochoa D; Villapalos-García G; Mejia-Abril G; Soria-Chacartegui P; Navares-Gómez M; de Miguel A; Román M; Martín-Vílchez S; Abad-Santos F
    Front Pharmacol; 2023; 14():1110460. PubMed ID: 36817149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paediatric adverse drug reactions reported to the Spanish Pharmacovigilance System from 2004 to 2009.
    Aldea A; García Sánchez-Colomer M; Fernández Quintana E; García Sáiz M
    Eur J Clin Pharmacol; 2012 Sep; 68(9):1329-38. PubMed ID: 22415248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of reports of otoxicity, with symptoms of tinnitus, in the database of the Spanish Pharmacovigilance System for medicinal products for human use.].
    Lisbona-Alquézar MP; Lanuza-Giménez J; Navarro-Pemán MC; Esteban-Jiménez Ó; Fernández-Alquézar Ó; Fernández-Liesa R
    Rev Esp Salud Publica; 2020 Dec; 94():. PubMed ID: 33226015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin and Norepinephrine Reuptake Inhibitors.
    Shelton RC
    Handb Exp Pharmacol; 2019; 250():145-180. PubMed ID: 30838456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incident adverse drug reactions in geriatric inpatients: a multicentred observational study.
    Lavan A; Eustace J; Dahly D; Flanagan E; Gallagher P; Cullinane S; Petrovic M; Perehudoff K; Gudmondsson A; Samuelsson Ó; Sverrisdóttir Á; Cherubin A; Dimitri F; Rimland J; Cruz-Jentoft A; Vélez-Díaz-Pallarés M; Lozano Montoya I; Soiza RL; Subbarayan S; O'Mahony D
    Ther Adv Drug Saf; 2018 Jan; 9(1):13-23. PubMed ID: 29318003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of adverse drug reaction/adverse event and early warning signal mining of Ginkgo biloba Dropping Pills based on SRS data].
    Zhang C; Liu H; Xie YM; Wang Q
    Zhongguo Zhong Yao Za Zhi; 2020 May; 45(10):2322-2328. PubMed ID: 32495588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reporting of suspected adverse drug reactions by nursing in Spain. An observational-descriptive retrospective study.
    Velasco-González V; Loya-Pérez L; Navarro-García E; Sáinz-Gil M
    Enferm Clin (Engl Ed); 2021; 31(6):363-370. PubMed ID: 34756240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Confidence and accuracy in identification of adverse drug reactions reported by outpatients.
    Kampichit S; Pratipanawatr T; Jarernsiripornkul N
    Int J Clin Pharm; 2018 Dec; 40(6):1559-1567. PubMed ID: 30367372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of a novel causality assessment scale for adverse events in non-small cell lung carcinoma patients treated with platinum and pemetrexed doublet chemotherapy.
    Sharma JB; Krishnamurthy MN; Awase A; Joshi A; Patil V; Noronha V; Prabhash K; Gota V
    Ther Adv Drug Saf; 2021; 12():2042098621991280. PubMed ID: 33628419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of pattern & distribution of adverse drug reactions in acute coronary syndrome patients in a tertiary care hospital.
    Mahadevappa M; Meher C; Pushpa NB; Kulkarni P; Poornima KS; Desai N
    Indian J Med Res; 2022 Jul; 156(1):111-121. PubMed ID: 36510903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Data-Driven Reference Standard for Adverse Drug Reaction (RS-ADR) Signal Assessment: Development and Validation.
    Lee S; Lee JH; Kim GJ; Kim JY; Shin H; Ko I; Choe S; Kim JH
    J Med Internet Res; 2022 Oct; 24(10):e35464. PubMed ID: 36201386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A tailor-made approach for causality assessment for ADR reports on drugs and vaccines.
    Oosterhuis I; Zweers P; Rümke H; Muller-Hansma A; van Puijenbroek EP
    Pharmacoepidemiol Drug Saf; 2019 Apr; 28(4):544-550. PubMed ID: 30168222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of three pharmacovigilance algorithms in the ICU setting: a retrospective and prospective evaluation of ADRs.
    Kane-Gill SL; Forsberg EA; Verrico MM; Handler SM
    Drug Saf; 2012 Aug; 35(8):645-53. PubMed ID: 22720659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia.
    Welsch P; Üçeyler N; Klose P; Walitt B; Häuser W
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD010292. PubMed ID: 29489029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of adverse drug reactions in Jordan: a retrospective analysis of the National Pharmacovigilance Data Registry (2015-2021).
    Mhaidat NM; Alshogran OY; Altawalbeh SM; Jaber JM; Banat HA; Ahmad DS; Alabsi W
    Expert Opin Drug Saf; 2023; 22(10):957-965. PubMed ID: 37293991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.